These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33637133)

  • 21. Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs.
    Rapaport C; Ashkenazi I
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Vaccination and Legal Preparedness: Lessons from Ireland.
    Tumelty ME; Donnelly M; Farrell AM; Ó Néill C
    Eur J Health Law; 2022 Mar; 29(2):240-259. PubMed ID: 35303721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultural competence in vaccine rollout: migrants would face difficulties accessing covid-19 vaccines.
    Waterman LZ
    BMJ; 2021 Jan; 372():n220. PubMed ID: 33500270
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid COVID-19 vaccine rollout: immense success but challenges ahead.
    Sandmann FG; Jit M
    Lancet Infect Dis; 2022 Mar; 22(3):302-304. PubMed ID: 34562376
    [No Abstract]   [Full Text] [Related]  

  • 25. Transparency of the national government as key in promoting the rollout of COVID-19 vaccines.
    Dela Cruz MDM; Mendoza AJM; Gueco GEA; Maghinang CJMP; Gopez JMW
    J Public Health (Oxf); 2021 Jun; 43(2):e381-e382. PubMed ID: 33783541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.
    Braun P; Haffner S; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):417-425. PubMed ID: 32646540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a nationwide booster vaccine rollout in Israel on SARS-CoV-2 infection and severe illness in young adults.
    Bomze D; Sprecher E; Gamzu R
    Travel Med Infect Dis; 2021; 44():102195. PubMed ID: 34737149
    [No Abstract]   [Full Text] [Related]  

  • 28. Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Plotkin SA; Halsey N
    Clin Infect Dis; 2021 Oct; 73(7):1320-1321. PubMed ID: 33502467
    [No Abstract]   [Full Text] [Related]  

  • 29. [Do we need a pediatric COVID-19 vaccine?].
    Eberhardt CS; Siegrist CA
    Rev Med Suisse; 2021 Feb; 17(726):353-357. PubMed ID: 33599412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equity and evidence during vaccine rollout: stepped wedge cluster randomised trials could help.
    Bell KJL; Glasziou P; Stanaway F; Bossuyt P; Irwig L
    BMJ; 2021 Feb; 372():n435. PubMed ID: 33579675
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 Vaccine Development to Vaccination.
    Pandey A; Belbase P; Parajuli A
    J Nepal Health Res Counc; 2021 Jan; 18(4):807-809. PubMed ID: 33510536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on Vaccines: Pandemic May Open Gateway to Improve Vaccination Rates in Texas.
    Price S
    Tex Med; 2021 Mar; 117(3):20-25. PubMed ID: 34855954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.
    Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X
    Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
    Simon HU; Karaulov AV; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 39. Communication, Health Literacy and a Systems Approach for Mitigating the COVID-19 Pandemic: The Case for Massive Vaccine Roll-out in Israel.
    Levin-Zamir D
    J Health Commun; 2020 Oct; 25(10):816-818. PubMed ID: 33719884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.